Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial Infarction

New England Journal of Medicine

Volumn 297, Issue 20, 1977, Pages 1091-1096

  Chalmers, Thomas C ^a   Matta, Raymond J ^a   Smith, Harry ^a   Kunzler, Anne Marie ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

DRUG THERAPY; EMBOLISM; HEART INFARCTION; REVIEW; STATISTICS; THEORETICAL STUDY; THERAPY; THROMBOEMBOLISM; THROMBOSIS;

EID: 0017745716     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197711172972004     Document Type: Article

References (46)

1. Link KP: The anticoagulant from spoiled sweet cloverhay. Harvey Lect 39: 162–216, 1943–1944
2. Greisman H, Marcus RM: Acute myocardial infarction: detailed study of dicumarol therapy in seventy-five consecutive cases. Am Heart J 36: 600–609, 1948
3. Smith FJ, Keyes JW, Denham RM: Myocardial infarction: a study of the acute phase in 920 patients. Am J Med Sci 221: 508–521, 1951
4. Furman RH, Ball COT, Gale RG, et al: An evaluation of anticoagulant therapy in myocardial infarction based on prognostic categories. Am J Med 14: 681–688, 1953
5. Loudon ISL, Pease JC, Cooke AM: Anticoagulants in myocardial infarction. Br Med J 1: 911–913, 1953
6. Schnur S: Mortality and other studies questioning the evidence for and value of routine anticoagulant therapy in acute myocardial infarction. Circulation 7: 855–868, 1953
7. Burton CR: Anticoagulant therapy of recent cardiac infarction. Can Med Assoc J 70: 404–408, 1954
8. Manson DI, Fullerton HW: Anticoagulant therapy in cardiac infarction. Br Med J 1: 6–8, 1956
9. Eastman GL, Cook ET, Shinn ET, et al: A clinical study of anticoagulants in acute myocardial infarction with particular reference to early heparin therapy. Am J Med Sci 233: 647–653, 1957
10. Honey GE, Truelove SC: Prognostic factors in myocardial infarction. Lancet 1: 1155–1161, 1209–1212, 1957
11. Rosenberg BA, Malach M: Acute myocardial infarction in city hospital. II. Experience with anticoagulants. Am J Cardiol 2: 71–80, 1958
12. Toohey M: Anticoagulants in myocardial infarction. Br Med J 1: 252–255, 1958
13. Richards RL, Seaton DA: Further observations on the value of anticoagulant therapy in the treatment of acute myocardial infarction. Scott Med J 6: 559–564, 1961
14. Blake TM, Orr ER, Simons JW: Ineffectiveness of anticoagulants in myocardial infarction. Am Heart J 63: 462–465, 1962
15. Griffith GC, Leak D, Hegde B: Conservative anticoagulant therapy of acute myocardial infarction. Ann Intern Med 57: 254–265, 1962
16. Gumpert TE: Anticoagulant treatment in 104 male cases of acute myocardial infarction. Lancet 1: 399–400, 1962
17. Meltzer LE, Palmon F, Ferrigan M, et al: Prothrombin levels and fatality rates in acute myocardial infarction. JAMA 187: 986–993, 1964
18. Modan B, Shani M, Schor S, et al: Reduction of hospital mortality from acute myocardial infarction by anticoagulant therapy. N Engl J Med 292: 1359–1362, 1975
19. Tonascia J, Gordis L, Schmerler H: Retrospective evidence favoring use of anticoagulants for myocardial infarctions. N Engl J Med 292: 1362–1366, 1975
20. Wright IS, Marple CD, Beck DF: Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction: (a progress report on the statistical analysis of the first 800 cases studied by this committee). Am Heart J 36: 801–815, 1948
21. Bresnick E, Selverstone LA, Rapoport B, et al: Experiences with Dicumarol in acute myocardial infarction. N Engl J Med 243: 806–810, 1950
22. Tullock JA, Gilchrist AR: Anticoagulants in treatment of coronary thrombosis. Br Med J 2: 965–971, 1950
23. Holten C: Anticoagulants in the treatment of coronary thrombosis. Acta Med Scand 140: 340–348, 1951
24. Feldman L, O'Connor WR, Friedman IA, et al: Anticoagulant therapy in acute myocardial infarction. Am Heart J 44: 112–118, 1952
25. Rashkoff IA, Schaefer LE, Magida MG, et al: Evaluation of dicumarol therapy in 287 cases of acute myocardial infarction. J Mt Sinai Hosp 18: 350–357, 1952
26. McCluskie JAW, Seaton DA: The value of anticoagulant therapy in treatment of acute myocardial infarction. Scott Med J 4: 305–309, 1959
27. Hilden T, Iverson K, Raaschou F, et al: Anticoagulants in acute myocardial infarction. Lancet 2: 327–331, 1961
28. Carleton RA, Sanders CA, Burack WR: Heparin administration after acute myocardial infarction. N Engl J Med 263: 1002–1005, 1960
29. Wasserman AJ, Gutterman LA, Yoe KB, et al: Anticoagulants in acute myocardial infarction: the failure of anticoagulants to alter mortality in randomized series. Am Heart J 71: 43–49, 1966
30. Assessment of short-term anticoagulant administration after cardiac infarction: report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Br Med J 1: 335–342, 1969
31. Drapkin A, Merskey C: Anticoagulant therapy after acute myocardial infarction: Relation of therapeutic benefit to patient's age, sex and severity of infarction. JAMA 222: 541–548, 1972
32. Handley AJ, Emerson PA, Fleming PR: Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br Med J 2: 436–438, 1972
33. Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial. JAMA 225: 724–729, 1973
34. Wright IS, Marple CD, Beck DF: Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction: (a progress report on the statistical analysis of the first 800 cases studied by this committee). Am Heart J 36: 801–815, 1948
35. Hurst JW, Logue RB: The clinical recognition and medical management of coronary atherosclerotic heart disease, The Heart: Arteries and veins. Third Edition. Edited by JW Hurst, RB Logue, RC Schlant, et al. New York, McGraw-Hil), 1974, pp 1038–1132
36. Krupp MA, Chatton MJ: Current Medical Diagnosis and Treatment. Los Altos, Lange, 1974, pp 195–196
37. Julian DG, Emslie-Smith D: Disease of the heart and circulation, Textbook of Medical Treatment. Thirteenth edition. Edited by S Alstead, RH Girdwood. London, Churchill Livingstone, 1974, pp 87–134
38. Oram S: Clinical Heart Disease. London, William Heinemann, 1971, pp 466–468
39. Friedberg CK: Diseases of the Heart. Philadelphia, Saunders, 1966, pp 987–992
40. Gifford RH, Feinstein AR: A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med 280: 351–357, 1969
41. Fisher RA: Statistical Methods for Research Workers. Hafner, New York, 1950, pp 99–101
42. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748, 1959
43. Chalmers TC, Block JB, Lee S: Controlled studies in clinical cancer research. N Engl J Med 287: 75–78, 1972
44. Peto R, Pike MC, Armitage NE, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34: 585–612, 1976
45. Freiman JA, Chalmers TC, Smith H: The role of beta error in the design and interpretation of the randomized clinical trial: survey of 100 negative trials. Paper presented at the meeting of the American Society of Clinical Investigators, Washington DC, May 1977
46. Chalmers TC, Koff RS, Grady GF: A note of fatality in serum hepatitis. Gastroenterology 49: 22–26, 1965